Showing results (181-190 of 281) with videos related to
Sort By:
Pageof 29
Psycho-Oncology|December 19, 2020
Breast cancer survivors' satisfying marriages predict better psychological and physical health: A longitudinal comparison of satisfied, dissatisfied, and unmarried womenM Rosie Shrout, Megan E Renna, Annelise A Madison, et al.The Journal of Biological Chemistry|December 3, 2015
Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) FunctionLi Ren, Amanda Campbell, Huiqing Fang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysisPolina Khrizman, Joyce C Niland, Anna ter Veer, et al.Scientific Reports|January 29, 2020
Guided migration analyses at the single-clone level uncover cellular targets of interest in tumor-associated myeloid-derived suppressor cell populationsSilvia Duarte-Sanmiguel, Vasudha Shukla, Brooke Benner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Inflammatory Cytokines and Comorbidity Development in Breast Cancer Survivors Versus Noncancer Controls: Evidence for Accelerated Aging?Catherine M Alfano, Juan Peng, Rebecca R Andridge, et al.Psychoneuroendocrinology|June 5, 2021
Distress Trajectories in Black and White Breast Cancer Survivors: From Diagnosis to SurvivorshipAnnelise A Madison, Juan Peng, M Rosie Shrout, et al.Molecular Cancer Therapeutics|January 28, 2010
Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosisKristan D Guenterberg, Valerie P Grignol, Ene T Raig, et al.Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.Cancer Immunology, Immunotherapy : CII|September 2, 2016
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomasMegan C Duggan, Caroline Jochems, Renee N Donahue, et al.Nature Communications|December 15, 2021
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapyWenqing Li, Xinfu Zhang, Chengxiang Zhang, et al.Pageof 29